Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Biohaven Gains As SK Biopharma Licenses Kv7 Epilepsy Platform In Global Deal

(RTTNews) - Biohaven Ltd. (BHVN), a biopharmaceutical company, on Wednesday announced a global licensing agreement with SK Biopharmaceuticals Co., Ltd. (326030.KS).

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

CBN to sell N700 billion Treasury Bills today in second August auction

The Central Bank of Nigeria (CBN), on behalf of the Debt Management Office (DMO), will offer N700 billion across the 91-day, 182-day and 364-day Treasury Bills tenors in the second and final Treasury…

  • CBN auctions N700 billion in Treasury Bills on August 26, 2026
  • NTB sale follows successful previous auction with N4.19 trillion bids

More from Wednesday 26 August →